These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

460 related articles for article (PubMed ID: 27031534)

  • 1. Prophylaxis of venous thromboembolism in cancer patients.
    Frere C; Doucet L; Farge D
    Expert Rev Hematol; 2016 Jun; 9(6):535-9. PubMed ID: 27031534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Venous thromboembolism in cancer patients.
    Deng A; Galanis T; Graham MG
    Hosp Pract (1995); 2014 Dec; 42(5):24-33. PubMed ID: 25485915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary prophylaxis of VTE in cancer outpatients.
    Imberti D; Benedetti R
    Thromb Res; 2016 Apr; 140 Suppl 1():S103-8. PubMed ID: 27067962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical practice guidelines for prophylaxis of venous thomboembolism in cancer patients.
    Frere C; Farge D
    Thromb Haemost; 2016 Sep; 116(4):618-25. PubMed ID: 27608595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Venous thromboembolism prevention in cancer outpatients.
    Khorana AA
    J Natl Compr Canc Netw; 2013 Nov; 11(11):1431-8. PubMed ID: 24225974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. American Society of Clinical Oncology guideline: recommendations for venous thromboembolism prophylaxis and treatment in patients with cancer.
    Lyman GH; Khorana AA; Falanga A; Clarke-Pearson D; Flowers C; Jahanzeb M; Kakkar A; Kuderer NM; Levine MN; Liebman H; Mendelson D; Raskob G; Somerfield MR; Thodiyil P; Trent D; Francis CW;
    J Clin Oncol; 2007 Dec; 25(34):5490-505. PubMed ID: 17968019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Venous thromboembolism and underutilisation of anticoagulant thromboprophylaxis in hospitalised patients with inflammatory bowel disease.
    Dwyer JP; Javed A; Hair CS; Moore GT
    Intern Med J; 2014 Aug; 44(8):779-84. PubMed ID: 24893756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of Thrombosis in Cancer: Clinical Factors and Role of Primary Prophylaxis.
    Roopkumar J; Khorana AA
    Cancer Treat Res; 2019; 179():55-68. PubMed ID: 31317480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): results obtained in France].
    Bergmann JF; Lloret-Linares C; Rami A; Cohen AT; Garay RP; Kakkar AK; Goldhaber SZ; Deslandes B; Tapson VF; Anderson FA;
    Presse Med; 2011 Dec; 40(12 Pt 1):e528-37. PubMed ID: 21964042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary venous thromboembolism prophylaxis in ambulatory cancer patients.
    Aikens GB; Rivey MP; Hansen CJ
    Ann Pharmacother; 2013 Feb; 47(2):198-209. PubMed ID: 23386067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of prophylaxis before the onset of acute venous thromboembolism among hospitalized cancer patients: the SWIss Venous ThromboEmbolism Registry (SWIVTER).
    Kucher N; Spirk D; Baumgartner I; Mazzolai L; Korte W; Nobel D; Banyai M; Bounameaux H
    Ann Oncol; 2010 May; 21(5):931-5. PubMed ID: 19828560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multicenter evaluation of the use of venous thromboembolism prophylaxis in acutely ill medical patients in Canada.
    Kahn SR; Panju A; Geerts W; Pineo GF; Desjardins L; Turpie AG; Glezer S; Thabane L; Sebaldt RJ;
    Thromb Res; 2007; 119(2):145-55. PubMed ID: 16516275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inpatient prophylaxis in cancer patients: where is the evidence?
    Patell R; Zwicker JI
    Thromb Res; 2020 Jul; 191 Suppl 1():S85-S90. PubMed ID: 32736785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The NCCN Clinical Practice Guidelines on Venous Thromboembolic Disease: strategies for improving VTE prophylaxis in hospitalized cancer patients.
    Khorana AA
    Oncologist; 2007 Nov; 12(11):1361-70. PubMed ID: 18055857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of evidence to support thromboprophylaxis in hospitalized medical patients with cancer.
    Carrier M; Khorana AA; Moretto P; Le Gal G; Karp R; Zwicker JI
    Am J Med; 2014 Jan; 127(1):82-6.e1. PubMed ID: 24384102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and efficacy of primary thromboprophylaxis in cancer patients.
    García Escobar I; Antonio Rebollo M; García Adrián S; Rodríguez-Garzotto A; Muñoz Martín A;
    Clin Transl Oncol; 2017 Jan; 19(1):1-11. PubMed ID: 27147252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modification of the National Inpatient Medication Chart improves venous thromboembolism prophylaxis rates in high-risk medical patients.
    Yates M; Reddy M; Machumpurath B; Phelps G; Hampson SA
    Intern Med J; 2014 Feb; 44(2):190-4. PubMed ID: 24528815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Venous thromboembolic disease.
    Streiff MB; Bockenstedt PL; Cataland SR; Chesney C; Eby C; Fanikos J; Fogerty AE; Gao S; Goldhaber SZ; Hassoun H; Hendrie P; Holmstrom B; Kuderer N; Lee JT; Millenson MM; Neff AT; Ortel TL; Siddiqi T; Smith JL; Yee GC; Zakarija A; McMillian N; Naganuma M;
    J Natl Compr Canc Netw; 2013 Nov; 11(11):1402-29. PubMed ID: 24225973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Venous thromboembolism in the patient with cancer: focus on burden of disease and benefits of thromboprophylaxis.
    Lyman GH
    Cancer; 2011 Apr; 117(7):1334-49. PubMed ID: 21425133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thromboprophylaxis in ambulatory lung cancer treatment.
    Cavaliere L
    Clin J Oncol Nurs; 2013 Feb; 17(1):74-9. PubMed ID: 23372099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.